Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury
There is no effective treatment for the total recovery of myocardial injury caused by an anticancer drug, doxorubicin (Dox). In this study, using a Dox-induced cardiac injury model, we compared the cardioprotective effects of ventricular cells harvested from 11.5-day old embryonic mice (E11.5) with...
Enregistré dans:
Auteurs principaux: | Mark Baguma-Nibasheka, Tiam Feridooni, Feixiong Zhang, Kishore B.S. Pasumarthi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/405a832b3dc947d2acd71feb9324bc7b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Síndrome de tako-tsubo, caracterización clínica y evolución a un año plazo
par: Ugalde,Héctor, et autres
Publié: (2017) -
Recurrencia de miocardiopatía por estrés posterior a terremoto en Chile: Reporte de un caso clínico
par: VARELA U,CECILIA, et autres
Publié: (2011) -
Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction
par: Tian XQ, et autres
Publié: (2017) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
par: Sousa,MG, et autres
Publié: (2014) -
Isoproterenol-Induced Cardiomyopathy Recovery Intervention: Amlexanox and Forskolin Enhances the Resolution of Catecholamine Stress-Induced Maladaptive Myocardial Remodeling
par: Gabriel Komla Adzika, et autres
Publié: (2021)